Services for Early Development
What would it be worth to your organization to achieve a successful product submission—even earlier than anticipated?
Our unique, patented Proveris by Design™ process measures the human usage performance of an OINDP according to current FDA and ICH guidelines for in vitro testing. Using a step-by-step protocol that takes pharmaceutical spray and aerosol drug products from pump selection to release testing, we can help streamline your submission package and give your application every chance to succeed.
Our scientific team employs rigorous Quality-by-Design (QbD) methodologies to:
Human Actuation Studies
Drug Product Characterization Studies
Device Formulation Screening
Novel Device Characterization
Drug Deposition Studies/ Alternative In-Vitro Approach
request a callback
From a Proveris Sales Associate